NCT00370786已完成3 期
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 31
- 试验地点
- 1
- 主要终点
- Visual acuity
研究概览
简要总结
To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.
排除标准
- •Evidence of AMD
研究组 & 干预措施
1
Experimental
干预措施: bevacizumab (Drug)
结局指标
主要结局
Visual acuity
时间窗: 6 months
次要结局
- central macular thickness(6 months)
- leakage in fluorescein angiography(6 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Intravitreal Bevacizumab in Agioid StreaksAngioid StreaksChoroidal NeovascularizationNCT00406250University of Campania "Luigi Vanvitelli"5
终止
3 期
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid StreaksAngioid StreaksChoroidal NeovascularizationNCT00599820Asociación para Evitar la Ceguera en México
已完成
4 期
Bevacizumab Intravitreal for Myopic Choroidal NeovascularizationMyopic Choroidal NeovascularizationNCT00797992Instituto de Olhos de Goiania5
终止
3 期
Efficacy of Retreatments With Intravitreal BevacizumabAge Related Macular DegenerationChoroidal NeovascularizationNCT00406744Asociación para Evitar la Ceguera en México20
已完成
4 期
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationAge Related Macular DegenerationNCT00556348Instituto de Olhos de Goiania500